Market-first feature leverages mobile and sensor technology via PAREXEL’s ClinPhone® RTSM mobile app to prevent temperature-compromised medication from reaching clinical trial patients
The new offering meets a growing need for the biopharmaceutical industry to manage the increasing number of critically temperature-sensitive medications being evaluated in clinical trials (“cold chain management”). By 2020, it is expected that eight out of the top 10 global biopharmaceutical products will require cold chain management. Research has shown that the majority of temperature excursions impacting medications occur during storage at the clinical site. Using wireless sensors combined with PAREXEL’s ClinPhone RTSM service, sites and logistics teams are able to track temperatures from the point of secondary packaging through dispensation to the patient.
“At PAREXEL, we continually innovate to better ensure patient safety and data accuracy while simplifying tasks for clinical trial sites. This important new functionality builds on the existing capabilities of PAREXEL’s Active Tracking Service and the ClinPhone® RTSM Mobile App to better manage the chain of custody record for clinical supplies,” said Ubavka DeNoble, Corporate Vice President of Patient Technology Services, PAREXEL. “For treatments that require cold chain handling, just a few degrees can make a huge difference, potentially impacting the safety of the medication, leading to the risk of the drug being unavailable for the next patient visit or affecting patient safety. With this new offering, clients will reduce safety risks and costs associated with temperature-compromised stock.”
The new feature will be demoed today and tomorrow during the CBI 7th Annual Interactive Response Technologies in Clinical Trials conference, taking place in Philadelphia, PA. It is the latest addition to PAREXEL’s Connected Journey™ of more than 40 data-driven services, and is currently available via the ClinPhone RTSM Mobile App.
PAREXEL’s ClinPhone RTSM service has been deployed on over 4,000 studies and more than 2.5 million patients, with the largest of those studies randomizing and supplying more than 60,000 patients. PAREXEL’s Active Tracking service controls and monitors the distribution of clinical trial supplies through its Clinical Trial Supplies and Logistics experts and global network of over 50 GMP compliant depots. The ClinPhone RTSM Mobile App is available worldwide for use on Android and iOS platforms.
“Global Trends in Clinical Trial Logistics: 2020 Perspective.” 2015. Corex.
About PAREXEL International
PAREXEL International Corporation is a leading global biopharmaceutical services company, providing a broad range of expertise-based clinical research, consulting, medical communications, and technology solutions and services to the worldwide pharmaceutical, biotechnology, and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, and reimbursement. PAREXEL Informatics provides advanced technology solutions, including medical imaging, to facilitate the integrated clinical development and regulatory information management process. Headquartered near Boston, Massachusetts, PAREXEL has approximately 18,900 employees with offices in 85 locations in 52 countries around the world. For more information about PAREXEL International visit www.PAREXEL.com.
PAREXEL and PAREXEL Informatics are trademarks or registered trademarks of PAREXEL International Corporation or its affiliates. All other trademarks are the property of their respective owners.
# # #
Tel.: +1 781-434-5104
Jenny Radloff, PAN Communications
Tel.: +1 617-502-4300